The polymorphisms in the VHL and HIF1A genes are associated with the prognosis but not the development of renal cell carcinoma

被引:53
作者
Qin, C. [1 ]
Cao, Q. [1 ]
Ju, X. [1 ]
Wang, M. [2 ]
Meng, X. [1 ]
Zhu, J. [1 ]
Yan, F. [2 ]
Li, P. [1 ]
Ding, Q. [1 ]
Chen, J. [1 ]
Gu, M. [1 ]
Zhang, W. [1 ]
Yin, C. [1 ]
Zhang, Z. [2 ,3 ]
机构
[1] Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing 210029, Jiangsu, Peoples R China
[2] Nanjing Med Univ, Sch Publ Hlth, Dept Mol & Genet Toxicol, Nanjing 210029, Jiangsu, Peoples R China
[3] Nanjing Med Univ, Sch Publ Hlth, Dept Occupat Med & Environm Hlth,Canc Ctr, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Nanjing 210029, Jiangsu, Peoples R China
关键词
HIF1A; polymorphism; prognosis; renal cell carcinoma; VHL; INDUCIBLE FACTOR-1-ALPHA GENE; ENDOTHELIAL GROWTH-FACTOR; FACTOR; 1-ALPHA; PROSTATE-CANCER; RISK; SUSCEPTIBILITY; HIF-1-ALPHA; SURVIVAL; PROLIFERATION; EXPRESSION;
D O I
10.1093/annonc/mdr325
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The von Hippel-Lindau (VHL) tumor suppressor gene and hypoxia-inducible factor-1 alpha (HIF1A) play a pivotal role in renal carcinogenesis. This study was aimed to clarify the influence of VHL and HIF1A polymorphisms on renal cell cancer (RCC) susceptibility and survival. Subjects and methods: We genotyped four potentially functional single-nucleotide polymorphisms (rs779805 in VHL and rs11549465, rs11549467, and rs2057482 in HIF1A) and assessed their associations with RCC risk, clinicopathologic parameters in a case-control study of 620 patients and 623 controls, and the prognosis of RCC in a cohort of 311 patients. Results: No significant differences in VHL or HIF1A genotypes were observed between RCC cases and controls. However, individuals with >= 2 variant alleles of the four polymorphisms were associated with less frequent lymph node metastasis and lower clinical stage (P = 0.032 and P = 0.041, respectively). And the number of variant alleles was associated with improved survival in a dose-response manner (P-trend = 0.013). Furthermore, multivariate Cox regression analysis showed that the number of variant alleles (>= 1 versus 0) was an independent prognostic factor for RCC survival (P = 0.036) together with clinical stage and tumor grade. Conclusion: The VHL and HIF1A polymorphisms may not influence RCC susceptibility but may jointly influence RCC progression and survival.
引用
收藏
页码:981 / 989
页数:9
相关论文
共 40 条
[1]   VHL and HIF signalling in renal cell carcinogenesis [J].
Baldewijns, Marcella M. ;
van Vlodrop, Iris J. H. ;
Vermeulen, Peter B. ;
Soetekouw, Patricia M. M. B. ;
van Engeland, Manon ;
de Bruine, Adriaan P. .
JOURNAL OF PATHOLOGY, 2010, 221 (02) :125-138
[2]   Expression of hypoxia-inducible factor-1 alpha (HIF-1α) in patients with the gallbladder carcinoma [J].
Batmunkh, Erdenebulgan ;
Shimada, Mitsuo ;
Morine, Yuji ;
Imura, Satoru ;
Kanemura, Hirofumi ;
Arakawa, Yusuke ;
Hanaoka, Jun ;
Kanamoto, Mami ;
Sugimoto, Koji ;
Nishi, Masaaki .
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2010, 15 (01) :59-64
[3]  
Birner P, 2000, CANCER RES, V60, P4693
[4]  
Brauch H, 2000, CANCER RES, V60, P1942
[5]  
Bui MHT, 2003, CLIN CANCER RES, V9, P802
[6]   Polymorphism in the hypoxia-inducible factor 1α gene may confer susceptibility to androgen-independent prostate cancer [J].
Chau, CH ;
Permenter, MG ;
Steinberg, SM ;
Retter, AS ;
Dahut, WL ;
Price, DK ;
Figg, WD .
CANCER BIOLOGY & THERAPY, 2005, 4 (11) :1222-1225
[7]   The pVHL-associated SCF ubiquitin ligase complex:: Molecular genetic analysis of elongin B and C, Rbx1 and HIF-1α in renal cell carcinoma [J].
Clifford, SC ;
Astuti, D ;
Hooper, L ;
Maxwell, PH ;
Ratcliffe, PJ ;
Maher, ER .
ONCOGENE, 2001, 20 (36) :5067-5074
[8]   Renal-cell carcinoma [J].
Cohen, HT ;
McGovern, FJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (23) :2477-2490
[9]   VHL Gene Mutations in Renal Cell Carcinoma: Role as a Biomarker of Disease Outcome and Drug Efficacy [J].
Cowey, C. Lance ;
Rathmell, W. Kimryn .
CURRENT ONCOLOGY REPORTS, 2009, 11 (02) :94-101
[10]   Prognostic significance of microscopic vascularity for clear cell renal cell carcinoma [J].
Delahunt, B ;
Bethwaite, PB ;
Thornton, A .
BRITISH JOURNAL OF UROLOGY, 1997, 80 (03) :401-404